Estimation of prevention-effective CAB-LA concentrations among men who have sex with men (MSM) and transgender women (TGW) in HPTN 083

By afschroeder • November 9, 2025

Hanscom B, Marzinke MA, Li X, Donnell D, Bies R, Hendrix CW, Wang Z, Acuipil C, Rinehart A, Collins JW, Rooney JF, Soto Torres L, Richardson P, Chariyalerstsak S, Valdez Ramalho Madruga J, Hurt CB, Magnus M, Frank I, McCauley M, Grinsztejn B, Landovitz RJ. Estimation of prevention-effective CAB-LA concentrations among men who have sex with men (MSM) and transgender women (TGW) in HPTN 083. J Infect Dis. 2025 Nov 5:jiaf561. doi: 10.1093/infdis/jiaf561. Epub ahead of print. PMID: 41206027.

Tags: Cabotegravir, Cabotegravir Pharmacokinetics, HIV PrEP, HPTN 083, Infectious Diseases, Long-acting PrEP, Publications

Prevalence, characteristics, and clinical course of mpox-related ophthalmic disease (MBOTE-EYE): a prospective cohort study in South Kivu, Democratic Republic of the Congo

Kabesha T, Van Dijck C, Mudwanga S, Houben S, Mujula Y, Munganga P, Tshomba JC, Mukari G, Wawina-Bokalanga T, Kinganda-Lusamaki E, Jacobs BK, Tsoumanis A,[...]

Determinants of PrEP Delivery Platform Choice in Adolescents and Young People: The Fast-PrEP Project in Cape Town, South Africa

Rousseau E, Bondarchuk C, Lebelo K, Matsebula L, Bennin F, Macdonald P, Pike C, Vanto O, Mathole N, Fynn L, Davey DJ, Coakley C, Wallace[...]

Proteomic Immune Signatures of Severe HIV-Associated Tuberculosis in Sub-Saharan Africa: A Prospective, Multicenter Analysis From Uganda

Ross JE, Tomoiaga AS, Owor N, Lu X, Shinyale J, Kiyingi T, Asasira I, Eliku PJ, Nsubuga JB, Nsereko C, Nayiga I, Kyebambe S, Ochar[...]